Functional dyspepsia
AC Ford, S Mahadeva, MF Carbone, BE Lacy… - The Lancet, 2020 - thelancet.com
Dyspepsia is a complex of symptoms referable to the gastroduodenal region of the
gastrointestinal tract and includes epigastric pain or burning, postprandial fullness, or early …
gastrointestinal tract and includes epigastric pain or burning, postprandial fullness, or early …
Gastroduodenal disorders
V Stanghellini, FKL Chan, WL Hasler, JR Malagelada… - Gastroenterology, 2016 - Elsevier
Symptoms that can be attributed to the gastroduodenal region represent one of the main
subgroups among functional gastrointestinal disorders. A slightly modified classification into …
subgroups among functional gastrointestinal disorders. A slightly modified classification into …
Клинические рекомендации Российской гастроэнтерологической ассоциации и ассоциации колопроктологов России по диагностике и лечению болезни …
Р Статья - Колопроктология, 2017 - ruproctology.com
1.1. Термины и определение Болезнь Крона (БК)–хроническое, рецидивирующее
заболевание желудочно-кишечного тракта неясной этиологии, характеризующееся …
заболевание желудочно-кишечного тракта неясной этиологии, характеризующееся …
Gastroparesis
M Camilleri, V Chedid, AC Ford, K Haruma… - Nature reviews Disease …, 2018 - nature.com
Gastroparesis is a disorder characterized by delayed gastric emptying of solid food in the
absence of a mechanical obstruction of the stomach, resulting in the cardinal symptoms of …
absence of a mechanical obstruction of the stomach, resulting in the cardinal symptoms of …
British Society of Gastroenterology guidelines on the management of functional dyspepsia
CJ Black, PA Paine, A Agrawal, I Aziz, MP Eugenicos… - Gut, 2022 - gut.bmj.com
Functional dyspepsia (FD) is a common disorder of gut–brain interaction, affecting
approximately 7% of individuals in the community, with most patients managed in primary …
approximately 7% of individuals in the community, with most patients managed in primary …
United European Gastroenterology (UEG) and European Society for Neurogastroenterology and Motility (ESNM) consensus on functional dyspepsia
L Wauters, R Dickman, V Drug, A Mulak… - …, 2021 - Wiley Online Library
Background Functional dyspepsia (FD) is one of the most common conditions in clinical
practice. In spite of its prevalence, FD is associated with major uncertainties in terms of its …
practice. In spite of its prevalence, FD is associated with major uncertainties in terms of its …
Functional dyspepsia
P Enck, F Azpiroz, G Boeckxstaens… - Nature Reviews …, 2017 - nature.com
Functional dyspepsia is one of the most prevalent functional gastrointestinal disorders.
Functional dyspepsia comprises three subtypes with presumed different pathophysiology …
Functional dyspepsia comprises three subtypes with presumed different pathophysiology …
Novel concepts in the pathophysiology and treatment of functional dyspepsia
L Wauters, NJ Talley, MM Walker, J Tack, T Vanuytsel - Gut, 2020 - gut.bmj.com
Emerging data increasingly point towards the duodenum as a key region underlying the
pathophysiology of functional dyspepsia (FD), one of the most prevalent functional GI …
pathophysiology of functional dyspepsia (FD), one of the most prevalent functional GI …
United European gastroenterology (UEG) and European Society for neurogastroenterology and motility (ESNM) consensus on gastroparesis
J Schol, L Wauters, R Dickman, V Drug… - …, 2021 - Wiley Online Library
Background Gastroparesis is a condition characterized by epigastric symptoms and delayed
gastric emptying (GE) rate in the absence of any mechanical obstruction. The condition is …
gastric emptying (GE) rate in the absence of any mechanical obstruction. The condition is …
Neuromodulators for functional gastrointestinal disorders (disorders of gut− brain interaction): a Rome foundation working team report
DA Drossman, J Tack, AC Ford, E Szigethy… - Gastroenterology, 2018 - Elsevier
Background & Aims Central neuromodulators (antidepressants, antipsychotics, and other
central nervous system− targeted medications) are increasingly used for treatment of …
central nervous system− targeted medications) are increasingly used for treatment of …